Discreet antiviral care for HSV-1 and HSV-2 — fast episodic treatment at the first tingle, or daily suppression to reduce how often outbreaks occur.

Valacyclovir is an oral tablet, prescription antiviral that is FDA approved to treat genital herpes and cold sores. It interferes with viral DNA synthesis, inhibiting replication and helping to control the infection. It does not cure the infection — the virus remains in the body, and outbreaks may still occur during times of weakened immunity or stress.
Valacyclovir is effective in reducing the frequency and severity of outbreaks. Taken during an active outbreak it can speed healing and reduce pain, itching, and blisters. Taken daily as suppressive therapy it can reduce the number of outbreaks and lower the risk of transmitting herpes to sexual partners, although additional precautions such as condoms are still recommended.
Episodic dosing started at the first sign can cut outbreak duration by days.
Suppressive therapy meaningfully reduces recurrence over the first few months.
Daily suppressive therapy can reduce the risk of transmitting herpes to partners.
Confidential virtual intake and discreet home delivery when prescribed.
Share your health history, medications, goals, and relevant medical information through a secure online questionnaire.
A licensed provider reviews your information and determines whether treatment may be medically appropriate.
If prescribed, receive your treatment instructions, supplies, and next steps.
Continue receiving provider support and access to educational resources throughout your treatment journey.
Valacyclovir is taken as an oral tablet, either episodically during an outbreak or daily for suppression. Dosage, frequency, administration instructions, and treatment duration should follow the individualized directions provided by your licensed provider.
Discreet antiviral care for HSV-1 and HSV-2 — fast episodic treatment at the first tingle, or daily suppression to reduce how often outbreaks occur.
See pricing & plansTreatment eligibility and final prescription are determined by a licensed provider.